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Abstract 
Fifteen plant species were collected from the Nelspruit Botanical Garden based on a list of plants 
provided by Phytomedicine Programme at the University of Pretoria and their ethnopharmacological 
information. Hexane, dichloromethane (DCM), acetone and methanolic extracts were screened for 
antimycobacterial activity against Mycobacterium smegmatis. The acetone extract of Milletia stulhimannii was 
the most active, showing activity against Mycobacterium smegmatis with minimum inhibitory concentration 
(MIC) value of 0.13 mg/ml. Acetone extracts for all plants had lower MIC values ranging between 0.11-1.25 
mg/ml against M. smegmatis. Milletia stulhimannii, Albizia gummifera, Xanthocercis zambesiaca and 
Barringtonia racemosa have shown  great potential as anti-tuberculosis agents. They were active against M. 
smegmatis with average MIC values of acetone extracts of 0.13 mg/ml.
Keywords: Tuberculosis, Antimycobacterial activity, Milletia stulhimannii, Minimum 
        inhibitory concentration
Introduction
Tuberculosis (TB) is a serious public health challenge of the 21st century and is still one of the most 
devastating diseases of mankind. It is estimated that there are 1.7 million deaths and up to 9.2 million new 
clinical cases of TB each year (World Health Organisation, 2008). The recent increase of TB is associated with 
the increasing infection with the human immunodeficiency virus (HIV) and the rapid spread of multidrug 
resistant TB strains.
Natural products from plants are proven templates for new drug development (Okunade et al., 2004), 
and have many interesting biological activities. A wide structural diversity of antimycobacterial compounds has 
been discovered from plants and other organisms including fungi and marine organisms. Several recent reviews 
have highlighted the underutilized potential of plant species and natural products as sources of antimycobacterial 
extracts and chemicals (Gibbons, 2004). Plant-derived antimycobacterial compounds belong to an exceptionally 
wide diversity of classes, among them alkaloids, terpenoids, coumarins, peptides and phenolics. Thus, medicinal 
plants remain an important resource to find original active drugs or new therapeutic agents. Over 350 natural 
products have been evaluated for their antimycobacterial activities (Newton et al., 2002). 
Herbal remedies play an essential role in traditional medicine in rural areas of South Africa, where these 
are often the therapeutic treatment of choice. The preparation of herbal medicine which depends on a cultural 
context may be obtained from healers as already prepared mixtures, or as unprepared raw materials. Although 
South Africa possesses a rich tradition in the use of medicinal plants and an outstanding floral diversity 
estimated at 251 220 species of vascular plants (Cracraft and Grifo, 1999), little research has been done on these
plants for antimycobacterial leads which could be used as therapeutic agents. 
Since there has been no anti-TB drug introduced in the past 30 years, there is an urgent need to search 
for and develop new, effective and affordable anti-TB drugs (Gautam et al., 2007). Therefore, in this study we 
screened 15 plants  traditionally used for treatment of TB-related symptoms (frequent coughs, chest ailments, 
bloody sputum, fever, etc) for  bioactivity  against tuberculosis. 
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Materials and Methods
Plant collection and Storage
Fifteen medicinal plants (Table 1) were selected based from a list of plants that were crudely screened 
by Phytomedicine Programme at the University of Pretoria. Leaves were collected at the Lowveld National 
Botanical Garden, Mpumalanga, South Africa, transported in sterile sealed, labelled containers to the laboratory 
where they were separately allowed to dry completely at room temperature.  The dried leaves were ground into a 
fine powder using an electric grinder and   stored in airtight containers in a dark place to prevent oxidation until 
the extraction stage.
Table1: Indigenous medicinal plants selected for antimycobacterial screening.
Selected Medicinal Plants
Scientific names Family names
Albizia gummifera (J.F. Gmel.) C.A. Sm. Mimosaceae
Annona senegalensis Pers. 
Annonaceae
Apodytes dimidiata subsp dimidiata E.Mey. ex Arn. Icacinaceae
Antidesma venosum E Mey. ex Tul. Euphorbiaceae
Barringtonia racemosa (L.) Roxb. Lecythidaceae
Kigelia africana (Lam.) Benth. Bignoniaceae
Kirkia acuminata Oliv. Simaroubaceae
Macaranga capensis Baill. Benth. ex Sim
Euphorbiaceae
Maytenus senegalensis (Lam.) Excell Celastraceae
Maytenus udanta (Thunb.) Blakelock Celastraceae
Millettia stuhlmannii Taub. Fabaceae
Sclerocarya birrea (A.Rich.) Hochst.
Anacardiaceae
Vangueria infausta subsp infausta Burch. Rubiaceae
Warburgia salutaris (Bertol. f.) Chiov.
Canellaceae
Xanthocercis zambesiaca (Baker) Dumaz-le Grand.
Fabaceae
Extraction procedure
The crude extracts were prepared according to the method of Kotze and Eloff (2002). Plant materials 
from each species were individually extracted by weighing 1 g of each finely ground samples and extracted with 
10 ml of a different solvent: hexane, dichloromethane (DCM), acetone and methanol in 50 ml Erlenmeyer flasks,
respectively.  The mixtures were vigorously shaken for 10 mins at high speed.  After centrifuging at 959 xg for 
10 mins, the supernatants were decanted into pre-weighed 50 ml Erlenmeyer flasks.  The extraction process was 
repeated three times to exhaustively extract the plant material.  The solvents were evaporated by air in a fume 
cupboard at room temperature and  the amount of extracts obtained was  quantified.
Antibacterial activity assays
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Test organisms
The Mycobacterium smegmatis was obtained from the School of Molecular and Cell Biology, 
University of Witwatersrand. The M. smegmatis was maintained on Middlebrook 7H9 broth containing 0.05% 
Tween 80 and 10% (v/v) ADC supplement (Albumin Fraction V, Dextrose and Catalase). The purity of the 
culture was checked by Ziehl-Neelsen staining before used in the antimicrobial assays.
In vitro broth microdilution screening assay
The antimycobacterial activities of the extracts were performed in 96-well microtiter plates as described 
by Eloff (1998). Fresh solutions of each crude extract and rifampicin (positive control) were prepared by first
dissolving these in acetone to 10 mg/ml; all tests were carried out in triplicate. Two-fold serial dilutions of each 
extract and rifampicin were made with 100 µl of each; sterile distilled water and 7H9 Middlebrook medium for
M. smegmatis in 96-well microplates, to yield final concentrations ranging from 2.5 mg/ml to 0.02 mg/ml for the 
crude extracts and the antibiotic. Rifampicin was included together with untreated controls. The plates were 
incubated at 37oC overnight. Forty microlitres of 0.2 mg/ml iodonitrotetrazolium chloride (INT) (Sigma-Aldrich) 
was added to each well and plates were further incubated for 30 mins at 37oC. Bacterial growth in the wells was 
indicated by a change in colour, whereas clear wells indicated inhibition by the extracts or positive control. 
Minimum Inhibitory Concentration values were recorded as the lowest concentrations of extracts showing no 
growth. The assay was repeated twice in triplicates each time.
Total activity of the extracts
The total activity in ml/g was calculated by dividing the quantity extracted from 1 g of plant material (in 
mg) with the MIC value. The resultant value indicates the volume to which the extract can be diluted and still 
inhibit the growth of a microorganism (Eloff, 2004).
Results and Discussion 
Mass extracted from the leaves of 15 medicinal plants using different solvents of varying polarity 
(hexane, dichloromethane, acetone and methanol) are shown in Figure 1. Methanol was the best solvent, 
extracting a greater quantity of plant material from leaves than the other solvents used. Hexane extracted the 
least amount of material. The extractability of these solvents is consistent with observations made by Masoko et 
al. (2008).
Figure 1: Mass of samples extracted by different solvents with varying polarity from 1 g of  
  starting material.
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Table  2: Average MIC (mg/ml) and total activity (ml/g) of selected plant species after 24 hrs incubation at 37oC.
na = No activity at 2.5 mg/ml
Rifampicin= 125 µg/ml
Minimal inhibitory concentration (mg/ml)
Albizia
gummifera
Kirkia
acuminata
Xanthocercis
zambesiaca
Milletia
stuhlmannii
Barringtonia
racemosa
Sclerocarya 
birrea
Maytenus 
udanta
Vangueria
infausta 
subsp
infausta
Macaranga 
capensis
Maytenus 
senegalensis
Apodytes
dimidiata 
subsp
dimidiata
Kigelia 
Africana
Antidesma
venosum
Hexane 1.25 0.63 1.667 0.31 0.63 0.523 1.25 1.25 0.63 0.104 1.25 0.63 1.25
DCM 0.31 0.31 1.25 0.31 0.63 0.63 1.25 1.25 0.523 na 1.043 1.667 1.25
Acetone 0.16 0.31 0.106 0.133 0.107 0.260 1.25 0.523 0.260 0.523 0.63 0.63 0.260
Methanol 0.31 0.63 0.63 0.260 0.837 0.417 1.25 1.043 0.417 1.25 na 0.63 0.837
Average 0.51 0.47 0.91 0.25 0.55 0.46 1.25 1.02 0.46 0.63 0.97 0.89 0.90
Total activity (ml/g)
Hexane 11.2 63.5 8.40 54.8 34.9 53.5 34.4. 43.2 30.2 144.2 20 14.3 16
DCM 151.6 190.3 52 190.3 65.1 200 72.8 62.4 91.8 na 51.8 26.4 31.2
Acetone 150 203.2 207.6 263.2 327.1 146.2 66.4 61.2 219.2 44 68.3 36.5 88.5
Methanol 254.8 387.3 168.3 257.7 176.8 326.1 101.6 87.3 266..2 75.2 na 33.3 126.6
Average 141.9 211.1 109.1 191.5 151.0 181.5 80.3 63.5 113.7 87.8 46.7 27.6 65.6
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Table 3: Average minimum inhibitory concentrations values of 4 medicinal plant acetone extracts showing the 
highest antimicrobial activity against Mycobacterium smegmatis after 24 hrs incubation at 37oC. 
Medicinal plants
Minimum inhibitory concentration 
(mg/ml)
Albizia gummifera 0.16
Xanthocercis zambesiaca 0.106
Barringtonia racemosa 0.107
Milletia stuhlmannii 0.133
Average 0.13
The results of the antimicrobial activity are shown in Table 2. Milletia stuhlmannii demonstrated the greatest 
antimicrobial effect as compared to the other plant extracts with MIC values as low as 0.13 mg/ml against 
Mycobacterium smegmatis. The MIC of the positive control was 125 µg/ml against M. smegmatis.
Acetone extracts of all plants had  lower MIC values ranging between 0.11- 1.25 mg/ml for M. 
smegmatis after 24 hrs (Table 2). Acetone extracts of Milletia stuhlmannii, Albizia gummifera, Xanthocercis
zambesiaca and Barringtonia racemosa showed promising antimycobaterial activities against M. smegmatis with 
an average MIC value of 0.13 mg/ml (Table 3). The observation that some crude extracts had higher MIC (low 
potency) may be due to two possibilities. Firstly, positive anti-TB compounds may be partially inhibited by other 
agents present in the crude extracts (antagonistic effect). Secondly, it could be that the active compounds are 
present in very low concentrations (Amoo et al., 2009).
Extracts with higher total activity values were considered the best for isolation of potential bioactive 
compounds. The extracts of Kirkia acuminata exhibited the highest total activity, followed by M. stuhlmannii
when compared to the others (Table 2). Thus, 1 g of K. acuminata and M. stuhlmannii acetone extract can be 
diluted to 211.1 ml and 191.5 ml, respectively, with water and still inhibit the growth of M. smegmatis.
In conclusion, four plants showed  low MIC values (Table 3) and these may have potential anti-TB 
compounds. Efforts are underway to identify and characterise the active constituents from these plants. 
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